Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cyclo Therapeutics Inc | CYTH | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.45 | 03:05:50 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.45 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.8924 - 2.57 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 1.45 | USD |
Cyclo Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 32.96M | 22.73M | - | 1.08M | -20.06M | -0.88 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cyclo Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYTH Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.29 | 1.57 | 1.26 | 1.41 | 32,586 | 0.16 | 12.40% |
| 1 Month | 1.37 | 1.57 | 1.10 | 1.31 | 43,042 | 0.08 | 5.84% |
| 3 Months | 1.77 | 1.92 | 1.10 | 1.53 | 97,590 | -0.32 | -18.08% |
| 6 Months | 1.01 | 2.115 | 0.92 | 1.56 | 102,905 | 0.44 | 43.56% |
| 1 Year | 1.23 | 2.57 | 0.8924 | 1.58 | 88,508 | 0.22 | 17.89% |
| 3 Years | 9.13 | 13.00 | 0.68 | 4.30 | 100,231 | -7.68 | -84.12% |
| 5 Years | 4.19 | 17.75 | 0.68 | 6.38 | 227,529 | -2.74 | -65.39% |
Cyclo Therapeutics Description
| Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex. |
